Position in RNTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$102,960
+$90,365 QoQ
Shares Held
99,000
+800.0% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#30
of 59 holders
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Warberg Asset Management LLC holds $403,990 across 6 Biotechnology names. RNTX ranks #2 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,000 | $301,030 | |
| 2 | RNTX |
Rein Therapeutics, Inc.
This page
|
99,000 | $102,960 | |
| 3 | BIVI |
Biovie Inc.
|
613,426 | $0 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
94,797 | $0 | |
| 5 | BCTX |
BriaCell Therapeutics Corp.
|
159,555 | $0 | |
| 6 | ERNA |
Ernexa Therapeutics Inc.
|
69,430 | $0 |
All Filings in RNTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,960 | 99,000 | Shares | Sole | 2026-08-11 | |
| 2025-09-30 | $12,595 | 11,000 | Shares | Sole | 2025-11-06 | |
| 2024-09-30 | $35,400 | 10,000 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $86,850 | 31,354 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||